Effect of Gefitinib Combined with Chemotherapy in Patients with Advanced NSCLC: A Retrospective Cohort Study

BACKGROUND: There are currently no methods for the treatment of reversible drug-resistant EGFR-TKI lung cancer in the clinical setting, and thus, the patients finally return to the currently used drugs. This study aimed to compare the efficacy of chemotherapy alone and gefitinib combined with chemot...

Descripción completa

Detalles Bibliográficos
Autores principales: Dai, Lili, Wang, Wei, Li, Wenli, Wu, Ya, Qu, Kaixin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8769059/
https://www.ncbi.nlm.nih.gov/pubmed/35068940
http://dx.doi.org/10.2147/IJGM.S342917

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8769059/
https://www.ncbi.nlm.nih.gov/pubmed/35068940
http://dx.doi.org/10.2147/IJGM.S342917

Ejemplares similares